A7842912
Terazosin Hydrochloride , >98.0%(HPLC) , 63074-08-8
Synonym(s):
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride;1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride dihydrate;Terazosin hydrochloride dihydrate
CAS NO.：63074-08-8
Empirical Formula: C19H26ClN5O4
Molecular Weight: 423.89
MDL number: MFCD00467965
| Pack Size | Price | Stock | Quantity |
| 50MG | RMB31.20 | In Stock |
|
| 250MG | RMB79.20 | In Stock |
|
| 1G | RMB159.20 | In Stock |
|
| 5g | RMB196.80 | In Stock |
|
| 25g | RMB669.60 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 261-263°C |
| storage temp. | Inert atmosphere,2-8°C |
| solubility | H2O: 25 mg/mL |
| form | powder |
| color | white to off-white |
| Water Solubility | Soluble in water at 20mg/ml. Also soluble in methanol or ethanol. |
| Stability: | Stable for 2 years as supplied. Solutions in distilled water may be stored at -20° for up to 3 months. |
Description and Uses
Terazosin hydrochloride is a highly water-soluble antihypertensive agent with a structure and profile closely related to that of prazosin.
An α-1-adrenergicblocker related to prazosin.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264-P270-P301+P312-P501 |
| Hazard Codes | Xn,Xi |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| RTECS | TK8044925 |
